RecruitingNot ApplicableNCT06576752

Management of Patients with Heart Failure At Home After Hospital Discharge

Contemporary Post-Discharge Management in Heart Failure At Home

Sponsor

University Hospital, Akershus

Enrollment

450 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Heart Failure

Summary

This study aims to assess whether patients with acute heart failure (HF) can achieve the same level of HF-therapies by digital follow-up at home as compared to hospital visits according to the STRONG-HF strategy. Patients admitted to hospital with acute HF will be enrolled and randomized to either follow-up at the hospital out-patient clinic or digital follow-up at home.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new approach to managing heart failure at home after being discharged from the hospital — specifically, increasing heart failure medications to optimal doses more quickly and safely, with close remote monitoring. **You may be eligible if...** - You were recently hospitalized for worsening heart failure (within 72 hours before screening) - Your NT-proBNP levels (a blood marker for heart failure severity) were elevated during hospitalization - Your blood pressure and heart rate are stable - You are currently on less than half the recommended dose of heart failure medications **You may NOT be eligible if...** - You are under 18 or over 85 years old - You are on dialysis or have severe kidney disease - You recently had a heart attack or major heart procedure - You have other serious conditions complicating your heart failure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDigital follow-up and uptitration of medications at home after hospital discharge for heart failure

Both arms will treat the patients according to the STRONG-HF intensive care strategy, as recommended by current guidelines. That is up-titration to at least half of maximum tolerated doses of HF medications at discharge, followed by up-titration to maximum tolerated doses after 2 weeks. Safety visits will be performed after 1, 3 and 6 weeks.

OTHERFollow-up and uptitration of medications at the hospital outpatient-clinic after hospital discharge for heart failure

Locations(2)

Akershus University Hospital

Lørenskog, Akershus, Norway

Drammen Hospital, Vestre Viken HF

Drammen, Vestre Viken, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06576752

Related Trials

RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

NCT0556806947 locations

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288652 locations